Vitamin D Levels May Affect Inflammatory Bowel Disease Treatment Success Rate
A recent study suggests that low blood vitamin D levels may reduce the chances of successful treatment for inflammatory bowel diseases (IBD), including colitis and Crohn’s.
Participants in the study included 173 patients with IBD who were clients of Brigham and Women’s Hospital in Boston. The information the researchers had included vitamin D levels and whether or not their treatments were successful.
After examining the data, the researchers found a significant association between vitamin D levels and remission rates from IBD. In fact, people with normal vitamin D levels at the onset of their treatment were 2.5 times more likely to go into remission after three months of treatment than those with the lowest levels.
Researchers from Brigham and Women’s Hospital conducted the study. It was published in the March 2017 issue of Alimentary Pharmacology & Therapeutics.
Previous studies have associated vitamin D with improved lipid profiles in diabetics, lower risk of asthma and allergies in children, reducing the risk of skin damage, reducing the risk of osteoporosis, combating diabetes, lower risk of cognitive decline, and improving age-related macular degeneration.
Vitamin D can be found in milk, fortified cereals, fish, and eggs. Your body also processes vitamin D from the sun but it becomes harder for our bodies to process it as we age. A high quality vitamin D supplement is always a good option if you feel that you’re not getting enough through diet and sun.